Image Alt

Resources

  /  Resources (Page 11)

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) is a preclinical stage pharmaceutical company with a groundbreaking focus on telomere regeneration and age-related inflammatory diseases. Its lead drug candidate, Telomir-1, presents a novel approach to extending telomeres, potentially reversing aging processes and addressing age related conditions such as osteoarthritis.

In the fast-paced world of technology, where materials like Lithium, Tin and Tantalum are increasingly in demand, and their supply security is becoming a top priority for the United States, Asia, and Europe, IberAmerican Lithium Corp (OTCQB: IBRLF; CBOE: IBER; FSE: W2C) presents a unique and strategic investment opportunity. With the pending acquisition of the Penouta Project in Spain, IberAmerican